Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

MadeMed Review

Doctor-backed compounded telehealth across GLP-1, peptides, NAD+, and sexual health, with oral alternatives to injections.

Last reviewed August 2026
2 studies cited
Fact-checked 12 August 2026Prices checked 15 June 2026From $99 – $349/moEditor Score 4.3 / 5

We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology

Quick Verdict

A solid compounded-only generalist with one of the lowest entry prices for oral semaglutide. The NAD+ and sermorelin menu is a real differentiator for longevity-curious buyers.

Pros
  • Low $99/mo entry price for oral semaglutide
  • Both injectable and oral routes for GLP-1
  • Wide peptide and NAD+ menu beyond pure weight loss
Cons
  • Compounded only — no brand-name Wegovy, Zepbound, Ozempic, or Mounjaro
  • NAD+ and oral GLP-1 absorption are less clinically validated than injection

MadeMed Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at MadeMed.

Program / Membership FeeIncluded in monthly plan
Medication Cost (From)From $99 – $349/mo
What This Means For You

MadeMed prices each protocol as a flat monthly fee that includes medication, board-certified physician consultation, and discreet shipping. Prices range from $99/mo for oral semaglutide up to $269/mo for NAD+ nasal spray.

Who MadeMed Is For

MadeMed fits readers who want a single clinic for compounded GLP-1 plus longevity peptides like NAD+ and sermorelin, and who appreciate having an oral route as a needle-free alternative. Less suited if you specifically need brand-name FDA-approved GLP-1.

How MadeMed Markets Itself

Adults who want doctor-backed compounded GLP-1, peptide, and sexual-health protocols with both injectable and oral routes.

Signature Programs

  • ›Oral and injectable semaglutide
  • ›Oral and injectable tirzepatide
  • ›NAD+ injectable & nasal spray
  • ›Sermorelin peptide protocols

Medication Formulary

Full Formulary
compounded semaglutide (oral & injectable)compounded tirzepatide (oral & injectable)oral glp-1 pillstadalafilinjectable sermorelinoral sermorelinnad+ injectablenad+ nasal spray

How MadeMed Scores

MadeMed scores 4.3 / 5 overall (cost 4.5, experience 4.2, trust 4.2), which makes it one of the strong mid-tier options in the GLP-1 weight loss category we cover.

See how MadeMed compares in our full GLP-1 weight loss rankings, or read the Best Compounded GLP-1 Telehealth Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

How much does MadeMed cost per month?

MadeMed's published pricing runs $99 to $349 per month. MadeMed prices each protocol as a flat monthly fee that includes medication, board-certified physician consultation, and discreet shipping. Prices range from $99/mo for oral semaglutide up to $269/mo for NAD+ nasal spray. Confirm the all-in monthly total at checkout, because telehealth pricing changes without notice.

What medications does MadeMed prescribe?

MadeMed lists compounded semaglutide (oral & injectable), compounded tirzepatide (oral & injectable), oral glp-1 pills, among others. It focuses on compounded medications rather than FDA-approved brand-name drugs. What you are prescribed depends on the clinician's assessment and your state.

Is MadeMed legit?

MadeMed connects patients with licensed clinicians for GLP-1 weight loss care. We score its trust and transparency at 4.2/5. Before ordering, check that the clinician is licensed in your state and, for compounded drugs, which pharmacy fills the prescription.

Can I cancel MadeMed anytime?

Most telehealth plans, MadeMed's included, are cancelled through the patient portal or support team, but refund terms vary. Compounded medication is made to order, so shipments are usually non-refundable once dispensed. Read the current terms before your first refill date to avoid an unwanted renewal.

References — Clinical Studies
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.

RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.

§ Readers Also Compared

How MadeMed Stacks Up

Alternatives To MadeMed

§ Continue Reading